Miami Beach, Dec. 11, 2012 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. formerly named Divine Skin Inc.,(OTCBB:DSKXD), a leading developer of personal care products,announced today it received confirmation that its application tolist the Company's common stock on the NASDAQ Capital Market hasbeen approved by the NASDAQ Stock Market, a unit of the NASDAQ OMXGroup. DS Healthcare Group common stock is expected to begin trading onthe NASDAQ Capital Markets, under the same symbol "DSKX" at theopening of trading on December 13, 2012. About DS Healthcare Group DS Healthcare Group, Inc. leads in thedevelopment of biotechnology for topical, and nutritionaltherapies. It markets through online and specialty retailers,distributors, cosmetics wholesalers and salons. Its brands includeDS Laboratories (www.DSLaboratories.com), SigmaSkin (www.SigmaSkin.com),Polaris Research Laboratories (www.PolarisReserachLabs.com)and Pure Guild (www.ThePureGuild.com). Forward-Looking Statements: Except for statements of historicalfact, the matters discussed in this press release areforward-looking and made pursuant to the Safe Harbor provisions ofthe Private Securities Litigation Reform Act of 1995."Forward-looking statements" describe future expectations, plans,results, or strategies and are generally preceded by words such as"future," "plan" or "planned," "expects," or "projected." Theseforward-looking statements reflect numerous assumptions and involvea variety of risks and uncertainties, many of which are beyond thecompany's control that may cause actual results to differmaterially from stated expectations. These risk factors include,among others, limited operating history, difficulty in developingand marketing products, intense competition and additional risksfactors as discussed in reports filed by the company with theSecurities and Exchange Commission, which are available at http://www.sec.gov.
CONTACT: Contact: Abner Silva Investor Relations DS Healthcare Group, Inc. 1.407.342.4112